Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOPA
3226
DELISTED
Society Pass
SOPA
| $79.1K | ﹤0.01% |
87,157
+74,880
| +610% | +$116K |
|
3227
Coya Therapeutics
COYA
$110M
| $78.9K | ﹤0.01% |
+12,200
| New | +$77.2K |
|
|
CARM
3228
DELISTED
Carisma Therapeutics
CARM
| $78.6K | ﹤0.01% |
253,657
+22,300
| +10% | +$9.88K |
|
|
LOT
3229
Lotus Technology
LOT
$603M
| $77.6K | ﹤0.01% |
+48,500
| New | +$122K |
|
|
BSIN
3230
Big Sky Industrial
BSIN
$73M
| $77.4K | ﹤0.01% |
64,500
+1,600
| +3% | +$3.03K |
|
3231
Vertical Aerospace
EVTL
$107M
| $76.3K | ﹤0.01% |
22,709
+3,909
| +21% | +$21.9K |
|
3232
Grove Collaborative
GROV
$44.4M
| $76.1K | ﹤0.01% |
56,400
+12,900
| +30% | +$19.9K |
|
3233
ProFrac Holding
ACDC
$936M
| $75.9K | ﹤0.01% |
+10,000
| New | +$76.8K |
|
3234
Inovio Pharmaceuticals
INO
$93M
| $74.7K | ﹤0.01% |
45,828
-196,477
| -81% | -$394K |
|
3235
Designer Brands
DBI
$311M
| $74.2K | ﹤0.01% |
+20,330
| New | +$95.6K |
|
3236
Milestone Scientific
MLSS
$48.9M
| $72.5K | ﹤0.01% |
77,756
-48,519
| -38% | -$53.2K |
|
3237
DarioHealth
DRIO
$72.9M
| $72K | ﹤0.01% |
5,880
+1,295
| +28% | +$18.3K |
|
3238
Getty Images
GETY
$133M
| $71.3K | ﹤0.01% |
41,200
-70,400
| -63% | -$167K |
|
|
FORA
3239
DELISTED
Forian
FORA
| $71.2K | ﹤0.01% |
35,600
+299
| +0.8% | +$667 |
|
|
ZEPP
3240
Zepp Health
ZEPP
$79.9M
| $70.5K | ﹤0.01% |
23,824
| – | – |
|
3241
Lexeo Therapeutics
LXEO
$400M
| $70.4K | ﹤0.01% |
+20,300
| New | +$89.9K |
|
|
FTH
3242
Faeth Therapeutics
FTH
$759M
| $69.9K | ﹤0.01% |
8,865
+1,025
| +13% | +$9.75K |
|
3243
Xenetic Biosciences
XBIO
$7.56M
| $69.9K | ﹤0.01% |
26,764
+1,214
| +5% | +$4.75K |
|
3244
Microvision
MVIS
$89.7M
| $69.7K | ﹤0.01% |
3,750
-86,298
| -96% | -$1.8M |
|
|
KORE
3245
DELISTED
KORE Group Holdings
KORE
| $68.8K | ﹤0.01% |
27,841
+5,200
| +23% | +$12.5K |
|
3246
Freightos
CRGO
$64.6M
| $68.1K | ﹤0.01% |
+28,500
| New | +$90.9K |
|
3247
Urban One Class A
UONE
$23.3M
| $67.8K | ﹤0.01% |
4,710
+10
| +0.2% | +$142 |
|
|
INCR
3248
Intercure
INCR
$57.1M
| $67.8K | ﹤0.01% |
48,400
+100
| +0.2% | +$162 |
|
3249
CalciMedica
CALC
$19.1M
| $67.6K | ﹤0.01% |
35,416
-7,784
| -18% | -$19.4K |
|
3250
Metalpha Technology Holding
MATH
$41.4M
| $67.5K | ﹤0.01% |
39,700
| – | – |
|
Similar funds
Jim Simons's Q1 2025 Portfolio in Review
As of Q1 2025, Jim Simons held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Jim Simons added most to Broadcom in Q1 2025, an estimated $513M increase.
- Jim Simons's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Jim Simons fully exited Nike in Q1 2025, selling an estimated $197M.
- Jim Simons's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Jim Simons opened 456 new positions and closed 583 in Q1 2025.
- Jim Simons's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.